Late events and clinical prognostic factors in stage I non small cell lung cancer

Two hundred and forty six consecutive patients with pathological T1-2 N0 M0 non-small cell lung cancer were reviewed. Median follow-up was 79 months (range 3–144). So far, 110 patients have relapsed (45.6%). Actuarial median time to recurrence was 26 months in the 45 patients with thoracic relapses...

Full description

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2002-08, Vol.37 (2), p.171-177
Main Authors: Pasini, Felice, Pelosi, Giuseppe, Valduga, Francesco, Durante, Emilia, de Manzoni, Giovanni, Zaninelli, Marta, Terzi, Alberto
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - mortality
Carcinoma, Non-Small-Cell Lung - pathology
Disease-Free Survival
Female
Humans
Late events
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Male
Medical sciences
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Non small cell lung cancer
Pneumology
Prognosis
Prognostic factor
Stage I
Survival Rate
Tumors of the respiratory system and mediastinum
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Two hundred and forty six consecutive patients with pathological T1-2 N0 M0 non-small cell lung cancer were reviewed. Median follow-up was 79 months (range 3–144). So far, 110 patients have relapsed (45.6%). Actuarial median time to recurrence was 26 months in the 45 patients with thoracic relapses versus 12 months of the 65 metastatic ( P
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(02)00040-5